GLOBAL PRIMARY CELL CULTURE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Global Primary Cell Culture Market Size and Trends

The global primary cell culture market size was valued at US$ 5.99 Billion in 2023 and is expected to reach US$ 13.30 Billion by 2031, growing at a Compound Annual Growth Rate (CAGR) of 10.5% from 2024 to 2031.

Figure 1. Global Primary Cell Culture Market Share (%), By Region, 2023

Primary Cell Culture Market Trends:

• Adoption of single-use technologies: The adoption of single-use technologies has significantly impacted the primary cell culture market in recent years. With single-use products, researchers can avoid cross-contamination issues associated with traditional reusable equipment as each component is disposable. This has boosted efficiency as the turnaround time between experiments has been reduced. Cells are also not exposed to harsh chemical cleaning procedures required for reusable equipment between uses. As a result, cell viability and performance are better preserved with single-use technologies. The shift to single-use is especially prominent as companies move towards developing personalized therapies. With single cells gaining importance, single-use technologies allow for the handling of tiny volumes effectively. They also help establish small footprint laboratories with minimal infrastructure requirements. This flexibility suits the evolving product development workflows in the cell therapy sector.
• Rising focus on 3D cell culture systems: The growing focus on 3D cell culture systems is having a significant impact on the primary cell culture market. 3D cell culture models are gaining popularity as they more closely mimic the in vivo microenvironment compared to traditional 2D cultures. Cells grown in 3D cultures have been shown to exhibit more physiological behaviors and responses. This has led to increased research in disease modeling, predictive toxicology, and drug discovery using 3D cultured cells. As more life science researchers recognize the advantages of 3D cultures, there is a rising demand for primary cells that can be used to setup various 3D culture platforms. Vendors in the primary cell culture market are continuously coming up with new product offerings tailored for 3D applications. For example, many are introducing primary cell types pre-optimized for growth in 3D matrices, like extracellular matrix and hydrogels. Some major players are also providing 3D culture-ready cells encapsulated in naturally-derived or synthetic matrices. This saves researchers the time required for the manual setting up of 3D cultures. The availability of extensive protocols and support for 3D culture of different cell types is also widespread. As new 3D culture models gain popularity in applications like organ-on-a-chip devices, there will be increased demand for primary cells demonstrating tissue-specific functionalities in vitro.